Edition:
United States

Ardelyx Inc (ARDX.OQ)

ARDX.OQ on NASDAQ Stock Exchange Global Market

2.93USD
3:59pm EST
Change (% chg)

$0.21 (+7.72%)
Prev Close
$2.72
Open
$2.71
Day's High
$2.97
Day's Low
$2.71
Volume
61,266
Avg. Vol
63,742
52-wk High
$8.07
52-wk Low
$2.54

Chart for

About

Ardelyx, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutics focuses on addressing cardiorenal and gastrointestinal (GI) diseases. It operates through the research, development and commercialization of biopharmaceutical products segment. The Company's products line includes cardiorenal portfolio and... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $173.36
Shares Outstanding(Mil.): 62.13
Dividend: --
Yield (%): --

Financials

  ARDX.OQ Industry Sector
P/E (TTM): -- 80.78 29.53
EPS (TTM): -0.96 -- --
ROI: -33.48 -0.25 13.00
ROE: -39.78 -3.01 14.69

BRIEF-Ardelyx Announces Pricing Of Public Offering Of Common Stock

* ARDELYX ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

May 22 2018

BRIEF-Ardelyx Announces Proposed Public Offering Of Common Stock

* ARDELYX INC - STARTED UNDERWRITTEN PUBLIC OFFERING OF UP TO $50 MLN OF SHARES OF ITS COMMON STOCK Source text for Eikon: Further company coverage:

May 21 2018

Earnings vs. Estimates